EYPT
EyePoint, Inc. · Healthcare · Market cap $344.0M
Insiders sold $21K net in the last 90 days ·1 seller, 1 buyer· latest Form 4 filed Aug 18, 2026
Insider Buying
$72K
reported purchases (SEC code P)
Insider Selling
$2.0M
reported sales (SEC code S)
Unique Insiders
5
in the rolling window
Latest filing
Aug 24, 2026
Zaderej Karen L.
EyePoint, Inc. (EYPT) has 25 SEC Form 4 filings (51 transaction rows) in the rolling window, disclosed by 5 distinct insiders. Most recent filing: Aug 24, 2026.
Inside the rolling window, 5 insiders at EyePoint, Inc. reported 2 open-market purchases totaling $72K and 10 open-market sales totaling $2.0M. The most active filer is Chief Medical Officer Ribeiro Ramiro with 6 filings. The most recent open-market filing is a purchase of 10,600 shares by Director Zaderej Karen L., dated Aug 18, 2026, worth $52K.
- Industry:Biotechnology
- CEO:Jay S. Duker
- Employees:214
- HQ:Watertown, MA, US
- IPO:2005-01-27
| Source | |||||||
|---|---|---|---|---|---|---|---|
Zaderej Karen L.First filing | Director | Purchase | 10,600 | $52K | Aug 18 | -27.1% | SEC ↗ |
| Chief Medical Officer | Sale | 4,875 | $73K | Jul 2 | -71.5% | SEC ↗ | |
| Chief Medical Officer | Sale | 2,437 | $37K | Apr 20 | -73.5% | SEC ↗ | |
Duker Jay S.First filing | President and CEO | Purchase | 1,500 | $20K | Mar 16 | -70.3% | SEC ↗ |
| Chief Medical Officer | Sale | 2,438 | $44K | Mar 5 | -74.7% | SEC ↗ | |
| Chief Medical Officer | Sale | 2,437 | $37K | Feb 18 | -72.2% | SEC ↗ | |
| Chief Medical Officer | Sale | 42,544 | $727K | Jan 7 | -77.0% | SEC ↗ | |
Cormorant Asset Management, LPFirst filing | Former 10% Owner | Sale | 60,000 | $942K | Dec 8 | -77.6% | SEC ↗ |
| Director | Sale | 9,300 | $140K | Dec 5 | -77.5% | SEC ↗ | |
Lurker NancyFirst filing | Director | Sale | 200 | $3K | Dec 1 | — | SEC ↗ |
Lurker NancyFirst filing | Director | Sale | 500 | $7K | Dec 1 | — | SEC ↗ |
Ribeiro RamiroFirst filing | Chief Medical Officer | Sale | 2,722 | $32K | Nov 12 | — | SEC ↗ |
Frequently asked questions
How many SEC Form 4 insider filings does EYPT have?
EyePoint, Inc. (EYPT) has 25 SEC Form 4 filings (51 transaction rows) in the rolling 365-day window, disclosed by 5 distinct insiders. Most recent filing: Aug 24, 2026.
When was the most recent SEC Form 4 filing for EYPT?
The most recent Form 4 filing for EYPT on Tracefour is dated Aug 24, 2026.
Who is the most active insider at EYPT?
The most active SEC Form 4 filer at EYPT in the rolling window is Chief Medical Officer Ribeiro Ramiro, with 6 filings.
What is the net insider flow at EYPT over the last 6 months?
Over the trailing 180 days, insiders at EYPT have net sold $81K based on SEC Form 4 disclosures.
What is the total insider buy and sell value at EYPT in the current window?
Inside the rolling window, insiders at EYPT bought $72K and sold $2.0M based on SEC Form 4 filings.
Can I get alerts for EYPT insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at EyePoint, Inc. (EYPT). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
EyePoint, Inc. is in the Healthcare sector.